After adjusted with other ESCC survival associated predictor, the SET8 genotype was identified as an independent predictor for ESCC outcome (relative risk, 2.250; 95% CI, 1.041–4.857; p = 0.039). Here, KMT5A is linked to esophageal squamous cell carcinoma.